홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
PDSB
#4175
PDS Biotechnology Corporation Common Stock
1.3
6
USD
+28.30%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+28.30%
월간 변동
+109.23%
6달 변화
+38.78%
년간 변동율
+23.64%
이전 종가
1.0
6
Open
1.3
6
Bid
Ask
Low
1.3
6
High
1.3
6
양
2
마켓
주식
헬스케어
PDSB
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
45.4 M
45.71 M
46.63 M
48.98 M
55.82 M
—
Valuation ratios
Enterprise value
54.07 M
33.33 M
48.64 M
41.2 M
33.15 M
156.33 M
Price to earnings ratio
-1.58
-1.27
-1.45
-1.23
-1.04
-4.98
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
-1.7
-1.31
-1.54
-1.31
-1.29
-5.44
Price to book ratio
3.13
0.47
0.66
0.62
3.86
5.61
EBITDA 비율에 대한 기업 가치
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.18
-0.18
-0.23
-0.26
-0.25
-0.92
Return on equity %
-0.42
-0.38
-0.59
-0.95
-0.82
-2.74
Return on invested capital %
-228.2
-213.29
-206.4
-257.75
-263.5
-940.95
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.64
2.33
2.92
2.09
2.98
10.31
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
0.48
0.4
0.46
0.52
0.55
1.93
Debt to equity ratio
1.15
0.85
1.16
1.9
1.83
5.73
Long term debt to total assets ratio
-0.02
0.4
0.46
0.52
0.55
1.93
Long term debt to total equity ratio
-0.06
0.84
1.16
1.89
1.82
5.71
Per share metrics
Operating cash flow per share
-0.23
-0.22
-0.2
-0.13
-0.08
-0.63
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
0.6
0.47
0.4
0.38
0.36
1.62
Cash per share
1.14
0.99
0.69
0.56
0.58
2.82
Net current asset value per share
1.24
1.05
0.73
0.6
0.61
2.99
Tangible book value per share
0.52
0.55
0.35
0.2
0.2
1.3
Working capital per share
0.77
0.6
0.48
0.31
0.4
1.79
Book value per share
0.52
0.55
0.35
0.2
0.2
1.3
뉴스
PDS Biotechnology Corporation (PDSB) Q4 2025 Earnings Call Transcript
VTSAX vs. VTI: Which Vanguard Fund Should You Buy in 2026? - TipRanks.com
PDS 바이오테크놀로지, 나스닥 최저 입찰가 미달 통지 받아
PDS Biotechnology receives Nasdaq notice for minimum bid price deficiency
VOO vs. VTI: Which Vanguard ETF Is the Smarter Buy for 2026? - TipRanks.com
PDS 바이오텍, 3상 시험 변경… 신속 승인 경로 추가
PDS Biotech amends Phase 3 trial to add accelerated approval path
PDS Biotech reports 9.6-month progression-free survival in prostate cancer study
PDS 바이오, 암 면역치료제 PDS0101 특허 확보
PDS Biotech secures patent for cancer immunotherapy PDS0101
PDS Biotech, FDA 회의 후 주가 급등: 승인 가속화 기대
PDS Biotech stock soars after FDA meeting provides accelerated approval path